ImmunityBio, Inc.
IBRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$67,253 | -$92,555 | -$129,666 | -$59,179 |
| Dep. & Amort. | $0 | $3,880 | $3,829 | $4,138 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $9,648 | $9,537 | $9,038 |
| Change in WC | $0 | -$5,554 | -$22,035 | -$10,842 |
| Other Non-Cash | -$1,654 | $4,835 | $52,430 | -$28,299 |
| Operating Cash Flow | -$68,907 | -$79,746 | -$85,905 | -$85,144 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1,081 | -$1,121 | -$2,111 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$15,061 | -$100 | -$6,089 |
| Inv. Sales/Matur. | $0 | $0 | $5,350 | $18,034 |
| Other Inv. Act. | -$181,361 | $0 | $0 | $0 |
| Investing Cash Flow | -$181,361 | -$16,142 | $4,129 | $9,834 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$4 | $0 | $64 |
| Stock Issued | $0 | $173,136 | $220 | $107,732 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $173,519 | -$322 | -$1,202 | -$867 |
| Financing Cash Flow | $173,519 | $172,810 | -$982 | $106,929 |
| Forex Effect | -$56 | $76 | -$10 | -$7 |
| Net Chg. in Cash | -$76,805 | $76,998 | -$82,768 | $31,612 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $138,142 | $60,660 | $143,912 | $112,300 |
| End Cash | $61,337 | $137,658 | $61,144 | $143,912 |
| Free Cash Flow | -$68,907 | -$80,827 | -$87,026 | -$87,255 |